These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 35688994)

  • 1. EQ-5D-5L: a value set for Romania.
    Olariu E; Mohammed W; Oluboyede Y; Caplescu R; Niculescu-Aron IG; Paveliu MS; Vale L
    Eur J Health Econ; 2023 Apr; 24(3):399-412. PubMed ID: 35688994
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Valuation of EQ-5D-5L Health States in Poland: the First EQ-VT-Based Study in Central and Eastern Europe.
    Golicki D; Jakubczyk M; Graczyk K; Niewada M
    Pharmacoeconomics; 2019 Sep; 37(9):1165-1176. PubMed ID: 31161586
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Population norms for the EQ-5D-3L and EQ-5D-5L in Romania.
    Olariu E; Caplescu R; Vale L; Niculescu-Aron IG; Oluboyede Y; Paveliu MS
    Health Qual Life Outcomes; 2023 Jul; 21(1):80. PubMed ID: 37507760
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Parallel Valuation of the EQ-5D-3L and EQ-5D-5L by Time Trade-Off in Hungary.
    Rencz F; Brodszky V; Gulácsi L; Golicki D; Ruzsa G; Pickard AS; Law EH; Péntek M
    Value Health; 2020 Sep; 23(9):1235-1245. PubMed ID: 32940242
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estimating an EQ-5D-3L Value Set for Romania Using Time Trade-Off.
    Paveliu MS; Olariu E; Caplescu R; Oluboyede Y; Niculescu-Aron IG; Ernu S; Vale L
    Int J Environ Res Public Health; 2021 Jul; 18(14):. PubMed ID: 34299864
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of an EQ-5D Value Set for India Using an Extended Design (DEVINE) Study: The Indian 5-Level Version EQ-5D Value Set.
    Jyani G; Sharma A; Prinja S; Kar SS; Trivedi M; Patro BK; Goyal A; Purba FD; Finch AP; Rajsekar K; Raman S; Stolk E; Kaur M
    Value Health; 2022 Jul; 25(7):1218-1226. PubMed ID: 35779943
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A hybrid modelling approach for eliciting health state preferences: the Portuguese EQ-5D-5L value set.
    Ferreira PL; Antunes P; Ferreira LN; Pereira LN; Ramos-Goñi JM
    Qual Life Res; 2019 Dec; 28(12):3163-3175. PubMed ID: 31201730
    [TBL] [Abstract][Full Text] [Related]  

  • 8. German Value Set for the EQ-5D-5L.
    Ludwig K; Graf von der Schulenburg JM; Greiner W
    Pharmacoeconomics; 2018 Jun; 36(6):663-674. PubMed ID: 29460066
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The EQ-5D-5L Valuation Study in Egypt.
    Al Shabasy S; Abbassi M; Finch A; Roudijk B; Baines D; Farid S
    Pharmacoeconomics; 2022 Apr; 40(4):433-447. PubMed ID: 34786590
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Utility Values for Health States in Ireland: A Value Set for the EQ-5D-5L.
    Hobbins A; Barry L; Kelleher D; Shah K; Devlin N; Goni JMR; O'Neill C
    Pharmacoeconomics; 2018 Nov; 36(11):1345-1353. PubMed ID: 30051267
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Developing the EQ-5D-5L Value Set for Uganda Using the 'Lite' Protocol.
    Yang F; Katumba KR; Roudijk B; Yang Z; Revill P; Griffin S; Ochanda PN; Lamorde M; Greco G; Seeley J; Sculpher M
    Pharmacoeconomics; 2022 Mar; 40(3):309-321. PubMed ID: 34841471
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estimating an EQ-5D-Y-3L Value Set for Indonesia by Mapping the DCE onto TTO Values.
    Fitriana TS; Roudijk B; Purba FD; Busschbach JJV; Stolk E
    Pharmacoeconomics; 2022 Dec; 40(Suppl 2):157-167. PubMed ID: 36348155
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A national survey of Iranian general population to estimate a value set for the EQ-5D-5L.
    Afshari S; Daroudi R; Goudarzi R; Mahboub-Ahari A; Yaseri M; Sari AA; Ameri H; Bahariniya S; Oliaei-Manesh A; Kalavani K; Zare Z; Hasannezhad E; Mirzaei M; Amiri Z
    Qual Life Res; 2023 Jul; 32(7):2079-2087. PubMed ID: 36897530
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Valuing Health State: An EQ-5D-5L Value Set for Ethiopians.
    Welie AG; Gebretekle GB; Stolk E; Mukuria C; Krahn MD; Enquoselassie F; Fenta TG
    Value Health Reg Issues; 2020 Sep; 22():7-14. PubMed ID: 31683254
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interim EQ-5D-5L Value Set for Poland: First Crosswalk Value Set in Central and Eastern Europe.
    Golicki D; Niewada M; Hout BV; Janssen MF; Pickard AS
    Value Health Reg Issues; 2014 Sep; 4():19-23. PubMed ID: 29702801
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Measuring health-related quality of life in the general population and Roma communities in Romania: study protocol for two cross-sectional studies.
    Olariu E; Paveliu MS; Baican E; Oluboyede Y; Vale L; Niculescu-Aron IG
    BMJ Open; 2019 Aug; 9(8):e029067. PubMed ID: 31427330
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A French Value Set for the EQ-5D-5L.
    Andrade LF; Ludwig K; Goni JMR; Oppe M; de Pouvourville G
    Pharmacoeconomics; 2020 Apr; 38(4):413-425. PubMed ID: 31912325
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An EQ-5D-5L Value Set for Ghana Using an Adapted EuroQol Valuation Technology Protocol.
    Addo R; Mulhern B; Norman R; Owusu R; Viney R; Nonvignon J
    Value Health Reg Issues; 2024 Sep; 45():101045. PubMed ID: 39236574
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Experience-Based Swedish TTO and VAS Value Sets for EQ-5D-5L Health States.
    Burström K; Teni FS; Gerdtham UG; Leidl R; Helgesson G; Rolfson O; Henriksson M
    Pharmacoeconomics; 2020 Aug; 38(8):839-856. PubMed ID: 32307663
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Value Set for the EQ-5D-Y-3L in Hungary.
    Rencz F; Ruzsa G; Bató A; Yang Z; Finch AP; Brodszky V
    Pharmacoeconomics; 2022 Dec; 40(Suppl 2):205-215. PubMed ID: 36123448
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.